See more : Tibet GaoZheng Explosive Co., Ltd. (002827.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Community Health Systems, Inc. (CYH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Community Health Systems, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Waja Company (9560.SR) Income Statement Analysis – Financial Results
- Tempus Resources Limited (TMR.AX) Income Statement Analysis – Financial Results
- Kronos Strategy ETP Securities (KRON.L) Income Statement Analysis – Financial Results
- LEG Immobilien SE (0QC9.L) Income Statement Analysis – Financial Results
- Grupo Industrial Saltillo, S.A.B. de C.V. (GISSAA.MX) Income Statement Analysis – Financial Results
Community Health Systems, Inc. (CYH)
About Community Health Systems, Inc.
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.49B | 12.21B | 12.37B | 11.79B | 13.21B | 14.16B | 15.35B | 18.44B | 19.44B | 18.64B | 13.00B | 13.03B | 11.91B | 11.40B | 12.11B | 10.84B | 7.13B | 4.37B | 3.74B | 3.33B | 2.83B | 2.20B | 1.69B | 1.34B | 1.08B |
| Cost of Revenue | 7.41B | 7.31B | 7.28B | 7.37B | 8.10B | 8.74B | 10.05B | 11.64B | 12.04B | 11.48B | 8.21B | 8.08B | 1.83B | 1.77B | 6.53B | 5.85B | 3.84B | 2.25B | 1.93B | 1.74B | 912.80M | 1.38B | 323.81M | 259.47M | 209.08M |
| Gross Profit | 5.08B | 4.91B | 5.08B | 4.42B | 5.11B | 5.42B | 5.31B | 6.80B | 7.40B | 7.16B | 4.79B | 4.95B | 10.07B | 9.63B | 5.58B | 4.99B | 3.29B | 2.11B | 1.80B | 1.59B | 1.92B | 817.99M | 1.37B | 1.08B | 870.87M |
| Gross Profit Ratio | 40.69% | 40.18% | 41.11% | 37.45% | 38.70% | 38.26% | 34.55% | 36.90% | 38.06% | 38.41% | 36.82% | 38.00% | 84.60% | 84.46% | 46.08% | 46.08% | 46.13% | 48.42% | 48.25% | 47.80% | 67.80% | 37.17% | 80.88% | 80.60% | 80.64% |
| Research & Development | 80.00M | 85.00M | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 2.49B | 1.54B | 1.23B | 1.10B | 1.49B | 1.84B | 1.06B | 825.29M | 683.96M |
| Other Expenses | 3.73B | 3.70B | 3.35B | 2.91B | 3.91B | 4.19B | 4.70B | 5.28B | 5.53B | 5.24B | 3.50B | 3.47B | 4.89B | 4.60B | 4.26B | 1.71B | 316.22M | 191.57M | 167.67M | 158.26M | 145.75M | 120.45M | 119.67M | 97.62M | 81.65M |
| Operating Expenses | 4.13B | 4.01B | 3.66B | 3.24B | 4.23B | 4.53B | 5.09B | 5.73B | 5.99B | 5.68B | 3.78B | 3.74B | 9.00B | 8.51B | 4.51B | 9.86B | 2.80B | 1.73B | 1.40B | 1.25B | 1.63B | 1.96B | 1.18B | 922.92M | 765.61M |
| Cost & Expenses | 11.53B | 11.32B | 10.94B | 10.62B | 12.33B | 13.27B | 15.14B | 17.36B | 18.03B | 17.16B | 12.00B | 11.82B | 10.84B | 10.28B | 11.04B | 9.86B | 6.64B | 3.99B | 3.33B | 2.99B | 2.54B | 1.96B | 1.50B | 1.18B | 974.70M |
| Interest Income | 2.00M | 2.00M | 3.00M | 3.00M | 3.00M | 7.00M | 11.00M | 0.00 | 0.00 | 0.00 | 2.98M | 0.00 | 4.65M | 1.76M | 3.56M | 7.06M | 8.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 832.00M | 858.00M | 885.00M | 1.03B | 1.04B | 976.00M | 931.00M | 962.00M | 973.00M | 972.00M | 615.15M | 622.93M | 649.06M | 653.68M | 648.96M | 658.98M | 364.53M | 102.30M | 94.61M | 77.86M | 71.09M | 62.86M | 94.55M | 0.00 | 0.00 |
| Depreciation & Amortization | 505.00M | 534.00M | 540.00M | 558.00M | 608.00M | 700.00M | 861.00M | 1.10B | 1.17B | 1.19B | 782.68M | 725.56M | 657.67M | 609.84M | 566.54M | 506.69M | 332.58M | 188.77M | 166.16M | 158.38M | 143.77M | 118.22M | 119.67M | 97.62M | 81.65M |
| EBITDA | 1.54B | 1.74B | 1.93B | 2.02B | 1.23B | 970.00M | -1.00B | 307.00M | 2.57B | 2.42B | 1.63B | 1.86B | 1.78B | 1.77B | 1.66B | 1.53B | 824.19M | 569.23M | 571.70M | 500.85M | 434.54M | 359.73M | 308.71M | 252.74M | 186.91M |
| EBITDA Ratio | 12.36% | 11.79% | 16.07% | 14.78% | 11.39% | 11.37% | 7.11% | 12.03% | 13.61% | 14.57% | 14.05% | 15.18% | 14.54% | 15.13% | 13.72% | 13.75% | 11.86% | 13.04% | 15.29% | 14.94% | 15.33% | 16.35% | 18.23% | 18.90% | 17.31% |
| Operating Income | 957.00M | 821.00M | 1.40B | 1.13B | 896.00M | 208.00M | -1.88B | -860.00M | 1.34B | 1.38B | 899.76M | 1.21B | 1.13B | 1.11B | 1.07B | 983.57M | 485.69M | 380.46M | 405.53M | 338.87M | 290.77M | 241.51M | 189.04M | 155.11M | 105.26M |
| Operating Income Ratio | 7.66% | 6.72% | 11.34% | 9.55% | 6.78% | 1.47% | -12.23% | -4.66% | 6.88% | 7.40% | 6.92% | 9.29% | 9.53% | 9.78% | 8.83% | 9.07% | 6.81% | 8.72% | 10.85% | 10.17% | 10.26% | 10.98% | 11.16% | 11.60% | 9.75% |
| Total Other Income/Expenses | -750.00M | -472.00M | -903.00M | -704.00M | -1.08B | -923.00M | -955.00M | -855.00M | -926.00M | -997.00M | -611.14M | -706.35M | -660.94M | -606.49M | -622.54M | -607.34M | -378.39M | -104.10M | -94.61M | -72.44M | -71.09M | -62.86M | -94.55M | -127.37M | -116.49M |
| Income Before Tax | 207.00M | 349.00M | 499.00M | 422.00M | -430.00M | -715.00M | -2.83B | -1.72B | 411.00M | 342.00M | 305.86M | 503.77M | 473.55M | 508.43M | 446.13M | 336.14M | 102.90M | 278.16M | 310.92M | 260.22M | 219.68M | 178.65M | 94.50M | 27.74M | -11.24M |
| Income Before Tax Ratio | 1.66% | 2.86% | 4.03% | 3.58% | -3.26% | -5.05% | -18.45% | -9.30% | 2.11% | 1.83% | 2.35% | 3.87% | 3.98% | 4.46% | 3.68% | 3.10% | 1.44% | 6.37% | 8.32% | 7.81% | 7.75% | 8.12% | 5.58% | 2.07% | -1.04% |
| Income Tax Expense | 191.00M | 170.00M | 131.00M | -185.00M | 160.00M | -11.00M | -449.00M | -104.00M | 116.00M | 82.00M | 88.59M | 157.50M | 137.65M | 159.99M | 141.33M | 129.48M | 43.00M | 106.68M | 120.78M | 102.00M | 88.21M | 73.39M | 45.94M | 18.17M | 5.55M |
| Net Income | -133.00M | 179.00M | 368.00M | 511.00M | -590.00M | -788.00M | -2.46B | -1.72B | 158.00M | 92.00M | 141.20M | 265.64M | 201.95M | 279.98M | 243.15M | 218.30M | 30.29M | 168.26M | 167.54M | 151.43M | 131.47M | 99.98M | 44.74M | 9.57M | -16.79M |
| Net Income Ratio | -1.06% | 1.47% | 2.98% | 4.33% | -4.47% | -5.57% | -16.02% | -9.33% | 0.81% | 0.49% | 1.09% | 2.04% | 1.70% | 2.46% | 2.01% | 2.01% | 0.42% | 3.85% | 4.48% | 4.54% | 4.64% | 4.54% | 2.64% | 0.72% | -1.55% |
| EPS | -1.02 | 1.39 | 2.90 | 4.42 | -5.19 | -6.99 | -22.00 | -15.55 | 1.38 | 0.82 | 1.51 | 2.98 | 2.24 | 3.05 | 2.68 | 2.34 | 0.32 | 1.77 | 1.89 | 1.58 | 1.34 | 1.02 | 0.51 | 0.14 | -0.31 |
| EPS Diluted | -1.02 | 1.38 | 2.82 | 4.38 | -5.19 | -6.99 | -22.00 | -15.54 | 1.37 | 0.82 | 1.51 | 2.96 | 2.23 | 3.01 | 2.66 | 2.32 | 0.32 | 1.75 | 1.79 | 1.51 | 1.30 | 1.00 | 0.50 | 0.14 | -0.31 |
| Weighted Avg Shares Out | 130.39M | 128.81M | 126.75M | 115.49M | 113.74M | 112.73M | 111.77M | 110.71M | 114.00M | 112.00M | 92.63M | 89.24M | 89.97M | 91.72M | 90.62M | 93.37M | 93.52M | 94.98M | 88.60M | 95.64M | 98.39M | 98.42M | 88.38M | 67.61M | 54.55M |
| Weighted Avg Shares Out (Dil) | 130.45M | 130.06M | 130.60M | 116.54M | 113.74M | 112.73M | 111.77M | 110.73M | 115.00M | 113.00M | 93.82M | 89.81M | 90.67M | 92.95M | 91.52M | 94.29M | 94.64M | 96.23M | 98.58M | 100.29M | 101.13M | 108.38M | 90.25M | 69.19M | 54.55M |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE:CYH). Such investors are advised to contact Danielle Peyton at [email protected]...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK , July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, June 30, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Community Health (CYH) & Cost Plus Drugs Expand Collaboration
Community Health (CYH) is now set to source drugs from the Cost Plus Drugs Marketplace under the new expanded partnership.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK , June 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Community Health Systems, Inc. Provides Update Regarding Lake Norman Regional Medical Center and Davis Regional Psychiatric Hospital
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) provided an update on the planned divestiture of two North Carolina hospitals today. On June 18, 2024, Novant Health, Inc., a North Carolina non-profit corporation (“Novant”), informed Community Health Systems, Inc. (the...
5 Hospital Stocks Set to Gain From Robust Industry Trends
The Zacks Medical-Hospital industry is gaining from growing patient volumes, utilization rates and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are expected to gain from these trends.
Community Health Systems (CYH) Up 9.2% Since Last Earnings Report: Can It Continue?
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock?
Community Health Systems, Inc. Announces Pricing of $1,225.0 Million Tack-On Offering of 10.875% Senior Secured Notes Due 2032
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has priced an offering of an additional $1,225.0 million aggregate principal amount of its outstanding 10.875% Senior...
Source: https://incomestatements.info
Category: Stock Reports